Log in

Relevant bibliographies by topics / Financial toxicity / Journal articles

To see the other types of publications on this topic, follow the link: Financial toxicity.

Journal articles on the topic 'Financial toxicity'

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Financial toxicity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Webster, Deacon Gregory. "Financial Toxicity." National Catholic Bioethics Quarterly 18, no. 2 (2018): 227–36. http://dx.doi.org/10.5840/ncbq201818223.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gallups, Sarah, and Brittany Moore. "Financial toxicity." Nursing 49, no. 10 (2019): 18–20. http://dx.doi.org/10.1097/01.nurse.0000577692.18934.ff.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nogueira, Luciana de Alcantara, Bruna Eloise Lenhani, Dabna Hellen Tomim, and Luciana Puchalski Kalinke. "Financial Toxicity." Asian Pacific Journal of Cancer Prevention 21, no. 2 (2020): 289–93. http://dx.doi.org/10.31557/apjcp.2020.21.2.289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kuehn, Bridget M. "Financial Toxicity." Circulation 140, no. 4 (2019): 336–37. http://dx.doi.org/10.1161/circulationaha.119.042159.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bordonaro, Roberto, Fabrizio Castagna, Dario Piazza, et al. "Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire." Journal of Clinical Oncology 38, no. 15_suppl (2020): e19389-e19389. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19389.

Full text

Abstract:

e19389 Background: Financial toxicity (FT) among cancer patients (CP) is multifactorial, arising from both disease-related and non- disease related factors, including socio-cultural, environmental, and psychological attributes. It derives both from costs related to assistance and borne on the patients and its caregivers, and reduction of income capacity also in this case borne on the patients and on the caregivers. Stress levels may escalate to significant proportions in some patient, to present with symptoms of anxiety especially during therapy administration periods. Methods: In order to hig

APA, Harvard, Vancouver, ISO, and other styles

6

Reff, Michael J., Hannah B. Peabody, and Deborah R. Walters. "Passionate Financial Support—An Antidote for Financial Toxicity." Oncology Issues 30, no. 3 (2015): 62–64. http://dx.doi.org/10.1080/10463356.2015.11884031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Conti, Rena M. "Financial Toxicity of Prescription Drugs." Annals of Internal Medicine 171, no. 9 (2019): 665. http://dx.doi.org/10.7326/m19-2899.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

O'Connor, Jeremy, Sheetal Kircher, and Jonas de Souza. "Financial toxicity in cancer care." Journal of Community and Supportive Oncology 14, no. 3 (2016): 101–6. http://dx.doi.org/10.12788/jcso.0239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Voit, Antanina, Sandra M. Quezada, Seema Patil, Emily Bellavance, Raymond K. Cross та Andrea Bafford. "Financial Toxicity in Crohnʼs Disease". American Journal of Gastroenterology 112 (жовтень 2017): S358. http://dx.doi.org/10.14309/00000434-201710001-00645.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Voit, Antanina, Raymond K. Cross, Emily Bellavance, and Andrea C. Bafford. "Financial Toxicity in Crohn’s Disease." Journal of Clinical Gastroenterology 53, no. 10 (2019): e438-e443. http://dx.doi.org/10.1097/mcg.0000000000001139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bouberhan, Sara, Meghan Shea, Alice Kennedy, et al. "Financial toxicity in gynecologic oncology." Gynecologic Oncology 154, no. 1 (2019): 8–12. http://dx.doi.org/10.1016/j.ygyno.2019.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Khera, Nandita. "Reporting and Grading Financial Toxicity." Journal of Clinical Oncology 32, no. 29 (2014): 3337–38. http://dx.doi.org/10.1200/jco.2014.57.8740.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

De Souza, Jonas A., Ellie Proussaloglou, Laura Nicholson, and Yichen Wang. "Evaluating financial toxicity (FT) interventions." Journal of Clinical Oncology 35, no. 15_suppl (2017): e21673-e21673. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e21673.

Full text

Abstract:

e21673 Background: FT has been defined as an adverse event of cancer treatments. Several patient (pt)-level interventions have been developed to mitigate FT. However, due to the lack of longitudinal studies, the impact of these interventions has not been established. Methods: Pts with cancer receiving Co-Pay Assistance (CPA) from the Patient Access Network Foundation were approached at baseline, 1 and 3 months post-CPA. We assessed the use of pt navigators, social workers, financial counselors, support groups, and transportation vouchers by pts. The outcomes were improvements in disease-specif

APA, Harvard, Vancouver, ISO, and other styles

14

Schroeder, Samuel R., Vijay Agusala, and David J. Sher. "Financial Toxicity and Cancer Therapy." Hematology/Oncology Clinics of North America 33, no. 6 (2019): 1117–28. http://dx.doi.org/10.1016/j.hoc.2019.08.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Parikh, Divya Ahuja, Sandy Srinivas, Elizabeth Kerr, and Manali I. Patel. "Addressing financial toxicity in urologic oncology patients." Journal of Clinical Oncology 39, no. 6_suppl (2021): 170. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.170.

Full text

Abstract:

170 Background: Financial toxicity, or the financial burden related to cancer care, is a source of distress for urologic oncology patients. This study aimed to address financial toxicity among prostate, kidney and bladder cancer patients and test the feasibility of a lay-health worker (LHW) and social work (SW) driven intervention. Methods: LHW assessed financial burden in urologic oncology patients with advanced cancer who presented for return visits at a single academic center. The LHW collected responses to three statements on a Likert scale – “I worry about the financial problems I will ha

APA, Harvard, Vancouver, ISO, and other styles

16

Susilowat, Maelani, and Yati Afiyanti. "Dampak Financial Toxicity Pada penyintas Kanker." Jurnal Ilmiah Ilmu Keperawatan Indonesia 10, no. 03 (2020): 72–77. http://dx.doi.org/10.33221/jiiki.v10i03.658.

Full text

Abstract:

Pendahuluan : Kanker merupakan salah satu penyakit yang memerlukan biaya medis yang cukup tinggi dalam perawatan dan pengobatannya sehingga dapat menyebabkan peningkatan tekanan psikososial, menurunnya kualitas dan kuantitas hidup bagi pasien kanker dan keluarga. Tujuan: systematic review untuk mengidentifikasi dampak dari diagnosis kanker pada penyintas kanker yang berkaitan dengan financial toxicity. Metode : Pencarian database yang digunakan yaitu ScienceDirect, EBSCO host, ProQuest, dan SpringerLink yang diidentifikasi dan dipublikasi dari tahun 2015-2020. Hasil : pencari

APA, Harvard, Vancouver, ISO, and other styles

17

Coughlin, Steven S., Justin Xavier Moore, and Jorge E. Cortes. "Addressing financial toxicity in oncology care." Journal of Hospital Management and Health Policy 5 (September 2021): 32. http://dx.doi.org/10.21037/jhmhp-20-68.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Sedhom, Ramy, Fumiko Chino, and Arjun Gupta. "Financial Toxicity and Cancer Care #409." Journal of Palliative Medicine 24, no. 3 (2021): 453–54. http://dx.doi.org/10.1089/jpm.2020.0699.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Messing, Edward M. "Financial Toxicity of Having Bladder Cancer." Bladder Cancer 4, no. 3 (2018): 351–52. http://dx.doi.org/10.3233/blc-189035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lyon, Debra. "COVID-19, Cancer, and Financial Toxicity." Oncology Nursing Forum 47, no. 3 (2020): 253–54. http://dx.doi.org/10.1188/20.onf.253-254.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Parikh, Divya Ahuja, Meera Vimala Ragavan, Sana Khateeb, and Manali I. Patel. "Financial toxicity among veterans with cancer." Journal of Clinical Oncology 37, no. 27_suppl (2019): 103. http://dx.doi.org/10.1200/jco.2019.37.27_suppl.103.

Full text

Abstract:

103 Background: Financial toxicity of cancer care has not previously been studied within the Veterans Health Administration (VHA). The VHA provides health care for veterans in VA hospitals across the United States (US). It is a single-payer system and the largest integrated health system in the US and in this study we sought to assess financial toxicity experienced by veterans at a VA hospital. Methods: We asked veterans with oncology clinic visits at the VA Palo Alto to complete a survey that included an 11-item validated questionnaire called the COST tool. The COST tool calculates a score 0-

APA, Harvard, Vancouver, ISO, and other styles

22

Liang, Margaret I., and Warner K. Huh. "Financial toxicity – An overlooked side effect." Gynecologic Oncology 150, no. 1 (2018): 3–6. http://dx.doi.org/10.1016/j.ygyno.2018.05.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Xu, Tingting, and Jing Wu. "Financial toxicity of cancer in China." Journal of Cancer Policy 15 (May 2018): 96–99. http://dx.doi.org/10.1016/j.jcpo.2018.02.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Xu, T., and J. Wu. "Financial Toxicity of Cancer in China." Journal of Global Oncology 4, Supplement 2 (2018): 155s. http://dx.doi.org/10.1200/jgo.18.17600.

Full text

Abstract:

Background and context: Cancer is not only a medical problem, but also a socioeconomical issue as the high prevalence with poor prognosis brings heavy financial burden to the society. From 2005 to 2013, the incidence and mortality rates have sharply increased in China. The most common types of cancer in males in China are lung cancer, gastric cancer, and liver cancer while breast cancer, lung cancer, colorectal cancer are the major types of cancer among Chinese females. The prognosis for most types of cancer is poor and the treatment costs have been high and hence cancer has caused significant

APA, Harvard, Vancouver, ISO, and other styles

25

Nesrine, M., R. Boujneh, A. Mnif, et al. "1879P Assessing financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST)." Annals of Oncology 31 (September 2020): S1069. http://dx.doi.org/10.1016/j.annonc.2020.08.1526.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lyman, Gary H., and Nicole Kuderer. "Financial Toxicity, Financial Abuse, or Financial Torture: Let’s Call It What It is!" Cancer Investigation 38, no. 3 (2020): 139–42. http://dx.doi.org/10.1080/07357907.2020.1735084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Inguva, Sushmitha, Masoom Priyadarshini, Ruchit Shah, and Kaustuv Bhattacharya. "Financial toxicity and its impact on health outcomes and caregiver burden among adult cancer survivors in the USA." Future Oncology 18, no. 13 (2022): 1569–81. http://dx.doi.org/10.2217/fon-2021-1282.

Full text

Abstract:

Aim: To examine the association between cancer-related financial toxicity on cancer survivors' physical and mental health outcomes and caregiver burden. Materials & methods: 2016–2017 Medical Expenditure Panel Survey data were used to identify adult cancer survivors with cancer-related financial toxicity. Multivariable regression analyses were employed to examine the association between cancer-related financial toxicity and cancer survivors' self-reported physical and mental health outcomes and caregiver burden. Results: A total of 53.7% of adult cancer survivors reported experiencing fina

APA, Harvard, Vancouver, ISO, and other styles

28

Silberstein, Alice, Mark A. Fiala, Sarah Kelley, Mark A. Schroeder, Keith E. Stockerl-Goldstein, and Ravi Vij. "Financial Toxicity Among Patients with Multiple Myeloma." Blood 138, Supplement 1 (2021): 4027. http://dx.doi.org/10.1182/blood-2021-153653.

Full text

Abstract:

Abstract Background: Treatment-related financial burden, or financial toxicity, can detract from mental health and quality of life and can lead patients to alter their care to offset treatment costs. In doing so, these patients compromise adherence which can contribute to disparities (Zafar Oncologist 2013). Among cancers, multiple myeloma treatment is particularly costly due to use of expensive, novel agents, often in combination, and for extended durations. One study found that patients with myeloma frequently reported financial toxicity and used coping strategies, including borrowing money

APA, Harvard, Vancouver, ISO, and other styles

29

Arsanjani, Reza, and Nandita Khera. "Financial Toxicity in Cancer and Cardiovascular Disease." JACC: CardioOncology 3, no. 2 (2021): 247–49. http://dx.doi.org/10.1016/j.jaccao.2021.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Zeybek, Burak, Emily Webster, Natalia Pogosian, et al. "Financial toxicity in patients with gynecologic malignancies." Gynecologic Oncology 162 (August 2021): S162. http://dx.doi.org/10.1016/s0090-8258(21)00950-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Keilson, Jessica M., Stacie Lindsey, Melinda Bachini, et al. "Patient report outcomes: Financial toxicity in cholangiocarcinoma." Journal of Clinical Oncology 40, no. 4_suppl (2022): 394. http://dx.doi.org/10.1200/jco.2022.40.4_suppl.394.

Full text

Abstract:

394 Background: While surgery is the only curative option for cholangiocarcinoma (CCA), it is amenable only in a minority of patients and has high recurrence rates. Numerous experimental and targeted therapies are under investigation; however, objective health-related quality of life (HRQoL) data for patients receiving these therapies are currently not available. Methods: Pts engaged in the Cholangiocarcinoma Foundation completed two validated HRQoL surveys: Functional Assessment of Cancer Therapy (FACT)-Hepatobiliary and COmprehensive Score for financial Toxicity (COST). Subscales (Physical W

APA, Harvard, Vancouver, ISO, and other styles

32

Nalley, Catlin. "Exploring Financial Toxicity Among Gynecologic Cancer Patients." Oncology Times 42, no. 9 (2020): 34. http://dx.doi.org/10.1097/01.cot.0000666596.32629.2c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Morrison, Chris. "'Financial toxicity' looms as cancer combinations proliferate." Nature Biotechnology 33, no. 8 (2015): 783–84. http://dx.doi.org/10.1038/nbt0815-783.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Knight, Thomas G., Myra Robinson, Michael R. Grunwald, et al. "Patient Reported Financial Toxicity in Acute Leukemia." Blood 132, Supplement 1 (2018): 4796. http://dx.doi.org/10.1182/blood-2018-99-119163.

Full text

Abstract:

Abstract Background: Financial Toxicity (FT) is increasingly recognized as a major contributor to morbidity and mortality in a variety of cancers. Treatment of acute leukemia is associated with heavy healthcare utilization and high costs. The purpose of this study was to define rates, risk factors, and mortality implications for FT in patients with acute leukemia using patient reported data. Methods: All patients seen at the Levine Cancer Institute, a tertiary hospital-based leukemia practice, were surveyed prior to each visit over a six-month period. All patients were aged ≥18 years and were

APA, Harvard, Vancouver, ISO, and other styles

35

Johnstone, Gregory P., and Peter A. S. Johnstone. "The Oncologist's Role in Managing Financial Toxicity." International Journal of Radiation Oncology*Biology*Physics 101, no. 2 (2018): 306–8. http://dx.doi.org/10.1016/j.ijrobp.2017.11.046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Knight, Thomas G., Myra Robinson, Jing Ai, et al. "Patient Reported Financial Toxicity in Myeloproliferative Neoplasms." Blood 134, Supplement_1 (2019): 2099. http://dx.doi.org/10.1182/blood-2019-128858.

Full text

Abstract:

Background: Financial Toxicity (FT) is increasingly recognized as a major contributor to morbidity and mortality in a variety of cancers. Previous research has demonstrated patients with myeloproliferative neoplasms (MPNs) exhibit a substantial comorbidity burden and have an increased risk of mortality. The purpose of this study was to define rates of FT and the implications on morbidity and mortality in this population using patient reported data. Methods: All patients seen at the Levine Cancer Institute, a tertiary hospital-based specialty practice, were surveyed prior to their visit over a

APA, Harvard, Vancouver, ISO, and other styles

37

Collyar, Deborah E. "Time to Treat Financial Toxicity for Patients." Cancer Journal 26, no. 4 (2020): 292–97. http://dx.doi.org/10.1097/ppo.0000000000000466.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Proussaloglou, Ellie M., Alex E. Rosenthal, Christina A. Raker, Jennifer Scalia Wilbur, Ashley R. Stuckey, and Katina M. Robison. "Financial toxicity in BRCA1 and BRCA2 carriers." Gynecologic Oncology 170 (March 2023): 160–66. http://dx.doi.org/10.1016/j.ygyno.2023.01.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Honda, Kazunori, Bishal Gyawali, Masashi Ando, et al. "Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer." Journal of Global Oncology, no. 5 (December 2019): 1–8. http://dx.doi.org/10.1200/jgo.19.00003.

Full text

Abstract:

PURPOSE We previously reported on the pilot study assessing the feasibility of using the Japanese translation of the Comprehensive Score for Financial Toxicity (COST) tool to measure financial toxicity (FT) among Japanese patients with cancer. In this study, we report the results of the prospective survey assessing FT in Japanese patients with cancer using the same tool. PATIENTS AND METHODS Eligible patients were receiving chemotherapy for a solid tumor for at least 2 months. In addition to the COST survey, socioeconomic characteristics were collected by using a questionnaire and medical reco

APA, Harvard, Vancouver, ISO, and other styles

40

Coughlin, Steven S., and Lorraine T. Dean. "Cancer survivorship care plans, financial toxicity, and financial planning alleviating financial distress among cancer survivors." Supportive Care in Cancer 27, no. 6 (2019): 1969–71. http://dx.doi.org/10.1007/s00520-019-04703-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Smith, Grace L., Robert Joseph Volk, Lisa M. Lowenstein, et al. "ENRICH: Validating a multidimensional patient-reported financial toxicity measure." Journal of Clinical Oncology 37, no. 27_suppl (2019): 153. http://dx.doi.org/10.1200/jco.2019.37.27_suppl.153.

Full text

Abstract:

153 Background: Financial toxicity is a patient-reported outcome reflecting burdens of cancer treatment costs. There is a need to assess financial toxicity in cancer care, as its unique domains—upstream factors like direct medical costs or downstream economic impact like bankruptcy—predict worse QOL, adherence, and mortality. Socioeconomically disadvantaged patients bear disparate financial toxicity burdens. We thus developed and report performance of a new measure, the Economic StraiN and Resilience in Cancer (ENRICh), to assess all financial toxicity domains in economically diverse patients.

APA, Harvard, Vancouver, ISO, and other styles

42

Mols, Floortje, Bianca Tomalin, Alison Pearce, Billingsley Kaambwa, and Bogda Koczwara. "Financial toxicity and employment status in cancer survivors. A systematic literature review." Supportive Care in Cancer 28, no. 12 (2020): 5693–708. http://dx.doi.org/10.1007/s00520-020-05719-z.

Full text

Abstract:

Abstract Background Financial toxicity has traditionally been attributed to the rising costs of cancer care. As ability to work impacts one’s financial situation, limited employment and reduced income may also contribute to financial toxicity. We examined evidence of the association between financial toxicity and employment status in cancer survivors. Methods A systematic literature review was performed via PubMed, Web of Science, CINAHL, and PsycINFO with search terms including “Cancer,” “Financial toxicity,” and “Employment” on September 25, 2019. Results Thirty-one papers met eligibility cr

APA, Harvard, Vancouver, ISO, and other styles

43

Smith, Grace L., Ya-Chen Tina Shih, and Steven J. Frank. "Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy." International Journal of Particle Therapy 8, no. 1 (2021): 366–73. http://dx.doi.org/10.14338/ijpt-20-00054.1.

Full text

Abstract:

Abstract Cancer-related financial toxicity impacts head and neck cancer patients and survivors. With increasing use of proton therapy as a curative treatment for head and neck cancer, the multifaceted financial and economic implications of proton therapy—dimensions of “financial toxicity”—need to be addressed. Herein, we identify knowledge gaps and potential solutions related to the problem of financial toxicity. To date, while cost-effectiveness analysis has been used to assess the value of proton therapy for head and neck cancer, it may not fully incorporate empiric comparisons of patients'

APA, Harvard, Vancouver, ISO, and other styles

44

Panzone, John, Christopher Welch, Ruben Pinkhasov, et al. "The influence of race on financial toxicity among cancer patients." Journal of Clinical Oncology 39, no. 15_suppl (2021): 1525. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1525.

Full text

Abstract:

1525 Background: Studies show that cancer patients and survivors are likely to endure financial toxicity long after being diagnosed. Methods: To examine the influence of race on financial toxicity among individuals with a history of cancer, a US based cross sectional study was conducted using data on 1,328 cancer patients collected from the Health Information National Trends Survey. Multivariable logistic regression analyses were used to analyze the relationship between race and financial toxicity, adjusting for known confounders. Results: Blacks, Hispanics and other races were shown to have a

APA, Harvard, Vancouver, ISO, and other styles

45

Knight, Thomas G., Allison M. Deal, Stacie B. Dusetzina, et al. "Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance." Journal of Oncology Practice 14, no. 11 (2018): e665-e673. http://dx.doi.org/10.1200/jop.18.00120.

Full text

Abstract:

Purpose: Because of the escalating cost of cancer care coupled with high insurance deductibles, premiums, and uninsured populations, patients with cancer are affected by treatment-related financial harm, known as financial toxicity. The purpose of this study was to describe individuals reporting financial toxicity and to identify rates of and reasons for affordability-related treatment noncompliance. Methods: From May 2010 to November 2015, adult patients (age ≥ 18 years) with cancer were identified from a Health Registry/Cancer Survivorship Cohort. Financial toxicity was defined as agreement

APA, Harvard, Vancouver, ISO, and other styles

46

Spencer, Jennifer, Katherine Elizabeth Reeder-Hayes, Laura C. Pinheiro, Lisa A. Carey, Andrew F. Olshan, and Stephanie B. Wheeler. "Short and long term impact of financial toxicity on quality of life in the Carolina Breast Cancer study." Journal of Clinical Oncology 35, no. 15_suppl (2017): e18299-e18299. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e18299.

Full text

Abstract:

e18299 Background: High cancer treatment costs are associated with considerable distress and worse outcomes in cancer patients, a phenomenon known as “financial toxicity”. We examined changes in health-related quality of life (HRQoL) among women experiencing financial toxicity after cancer diagnosis compared to cancer patients without financial toxicity in a racially diverse cohort of breast cancer patients. Methods: HRQoL was self-reported at approximately 5 and 25 months post-diagnosis using the Functional Assessment of Cancer Treatment (FACT-G) in a prospective, population-based, cohort stu

APA, Harvard, Vancouver, ISO, and other styles

47

De Souza, Jonas A., Bonnie J. Yap, Fay J. Hlubocky, and Christopher Daugherty. "Relationship between the cancer-specific comprehensive score for financial toxicity (COST), patient-reported outcome, and health-related quality of life (HRQOL) in patients with advanced cancers." Journal of Clinical Oncology 32, no. 31_suppl (2014): 222. http://dx.doi.org/10.1200/jco.2014.32.31_suppl.222.

Full text

Abstract:

222 Background: Financial toxicity is an important Patient Reported Outcome (PRO). Its relationship with HRQOL has not been previously described. Therefore, we report the relationship between financial toxicity and HRQOL in patients with advanced cancers. Methods: HRQOL was measured by the EORTC QLC-C30 global health status and its functional scales. Financial toxicity was assessed by the COST (COmprehensive Score for financial Toxicity), a cancer-specific PRO measure developed in 155 patients with advanced cancers. The Personal Financial Wellness Scale (PFW), a non-cancer specific financial m

APA, Harvard, Vancouver, ISO, and other styles

48

Brondfield, Samuel Craig, Hala Borno, Claire Mulvey, Li-Wen Huang, and Pelin Cinar. "Implementation of a fellow-initiated financial toxicity screening tool in medical oncology clinics." Journal of Clinical Oncology 36, no. 30_suppl (2018): 64. http://dx.doi.org/10.1200/jco.2018.36.30_suppl.64.

Full text

Abstract:

64 Background: Financial toxicity is an increasingly recognized problem for patients receiving cancer treatment, particularly in the high-cost precision medicine era. Financial toxicity is linked to asset depletion, debt, and bankruptcy. To address this imminent concern, we designed, implemented, and evaluated a fellow-initiated financial toxicity screening tool for use in medical oncology clinics. Methods: An interprofessional team of University of California San Francisco (UCSF) social workers and physicians selected three highly rated items from the COST measure, a published financial toxic

APA, Harvard, Vancouver, ISO, and other styles

49

Herriges, Michael Joseph, Rachel Shenhav-Goldberg, Juliet Irene Peck, et al. "Financial toxicity and its effect on screening for prostate and colon cancer." Journal of Clinical Oncology 40, no. 6_suppl (2022): 21. http://dx.doi.org/10.1200/jco.2022.40.6_suppl.021.

Full text

Abstract:

21 Background: The term ‘financial toxicity’ or ‘hardship’ is used to describe the financial problems patients experience due to high out-of-pocket costs for their healthcare. Financial toxicity in the context of cancer treatment is an area of recent study due to the significant costs associated with these treatments, but little is known about the effect of financial toxicity on cancer prevention. We examined the effects of financial toxicity on the utilization of screening tests for prevalent cancers, including prostate and colon cancer, using a US nationally representative survey-based data

APA, Harvard, Vancouver, ISO, and other styles

50

Kunos, Charles A., and Rita Abdallah. "Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer." Pharmaceuticals 13, no. 8 (2020): 181. http://dx.doi.org/10.3390/ph13080181.

Full text

Abstract:

Financial toxicity or the debt a cancer survivor incurs from the costs of their medical cancer care is an understudied aspect in the clinical development of experimental therapeutic agents. The United States National Cancer Institute (NCI) Cancer Therapy Evaluation Program studies experimental therapeutic agents like radiopharmaceuticals in both early and late phase trials, which provide opportunities to comprehend more clearly the possible sources of financial toxicity incurred by cancer survivors. We reviewed the academic scholarship describing fiscal and social costs involved in the develop

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!